Introduction
Patients who experience an acute myocardial infarction (MI) have an increased risk of malignant ventricular arrhythmias (VAs) that may lead to sudden cardiac death (SCD). 1 Risk stratification in this population is important to determine whether patients may benefit from implantable cardioverter-defibrillator (ICD) therapy. Left ventricular (LV) dysfunction [ejection fraction (EF) < 35%] is the most established parameter for selection of ICD patients 2 but has demonstrated limited ability in prediction of outcomes. 3 Thus, the current selection criteria for ICD needs to be further refined. The importance of right ventricular (RV) function for the occurrence of VA/SCD in the post-MI population is largely unknown. An MI is often considered as an LV pathology, but studies have demonstrated that RV function is a critical determinant of outcome in conditions such as congestive heart failure 4, 5 and MI. 6 Specifically with regard to arrhythmia, it has been proposed that patients with evidence of RV involvement after an inferior MI are at increased risk. 6 Furthermore, in patients receiving cardiac resynchronization therapy, it has been proposed that favourable RV remodelling is related to reduced arrhythmic risk. 7 It therefore seems plausible that RV dysfunction is an independent marker of VA/SCD in post-MI patients.
For the purpose of evaluating RV function, deformation analysis by 2D strain echocardiography (2DSE) may be a valuable tool. 8, 9 Applied to the left ventricle, 2DSE-derived measures, such as the mechanical dispersion (MD) or global longitudinal strain (GLS), have been shown to improve risk stratification for the occurrence of arrhythmia. 10, 11 Recent studies have indicated that RV strain (RVS) may also be superior to traditional markers of global RV function in prediction of clinical outcomes. 12, 13 Based on a large contemporary cohort of patients with acute MI, we hypothesized that detailed analysis of RV deformation would provide important prognostic information in relation to malignant VA.
Methods

Study design and patient population
As previously described, 14 patients were prospectively enrolled from two tertiary cardiac centres when referred for invasive coronary angiography due to either ST-segment elevation or non-ST-segment elevation MI. Exclusion criteria were age <18 years, non-cardiac disease with a life expectancy <1 year and an inability to provide written informed consent.
Patients with atrial fibrillation, severe valve disease and paced rhythm at the time of the echocardiography were excluded. In addition, the patients with suboptimal image quality for 2D strain analysis of either the right ventricle or the left ventricle were excluded ( Figure 1 ). Demographics were acquired from chart reviews regarding diabetes, hypertension, history of ischaemic heart disease or MI and objective signs of heart failure (Killip class). Information related to the coronary angiography, including culprit lesion, number of diseased vessels, left main involvement and type of revascularization (percutaneous coronary intervention, coronary artery bypass grafting or no intervention) were registered. Peak troponin I level was measured in 220 (28%) patients, peak troponin T level was measured in 558 (71%) patients and 12 (1%) patients had missing values. All patients provided written informed consent. The study protocol was approved by the regional scientific ethics committee (reference no. H-D-2009-063).
Echocardiography
Echocardiography was performed within 48 h of admission to the tertiary centre. Three consecutive heart cycles were acquired. All examinations were performed on a Vivid e9 system (General Electric, Horten, Norway). Images were obtained at a frame rate of at least 50 frames/s and analysed offline (Echopac BT 11.1.0, General Electric). All analyses were performed by a single experienced operator (M.E.) who was blinded to follow-up information. Measurements of LV volumes and function, LVEF, LV end-diastolic volume (EDV) and LV end-systolic volume (ESV) were performed using biplane Simpson model.
2D strain analysis
The 2D strain analysis was performed on both the LV in the three apical (long-axis, 4-chamber, and 2-chamber) views 15 and the RV four-chamber view. 16 All analyses, for both RV and LV, were optimized to be performed at a frame rate of 50-90 frames/min. Aortic valve closure was identified from continuous-wave Doppler recordings through the aortic valve. The endocardial border was traced in end systole and the automatically generated region of interest (ROI) was adjusted to exclude the pericardium. The integrity of speckle tracking was automatically detected and visually ascertained. In case of poor tracking, the ROI tracing was readjusted. Segments with persistent inadequate tracking were excluded from analysis.
LV strain analysis
The LV was divided into 17 segments covering the entire myocardium, and GLS was calculated as the mean of the global peak systolic strain from each of the three views. If global peak systolic strain could be assessed only in two of the three apical projections, GLS was calculated as the mean of these two. If global peak systolic strain could not be assessed in at least two of the apical projections, the patient was excluded from the study due to suboptimal image quality. The MD was calculated as the standard deviation (SD) of the time-topeak strain measured from the peak electrocardiographic (ECG) R-wave to peak negative strain for all segments. If six or more segments did not have sufficient tracking, then the measure was excluded. 10 
RV strain analysis
The RVS was used as a measure of global RV function, because the septal wall was included in the analysis of LV GLS, which has previously been shown to be the strongest predictor of arrhythmia in the current cohort. 10 The measurement of RVS required all three segments in the RV free wall (basal, midventricular and apical) to be reliably tracked or else it was excluded. RV MD included all the six RV segments and was calculated as the SD of the time-to-peak strain measured from the ECG peak R-wave to peak negative strain for each segment ( Figure 2) . If more than 2 segments were insufficiently tracked, the measurement was excluded.
Intra-and interobserver reproducibility
The intra-and inter-observer reproducibility has previously been described in detail 12 and was good with coefficients of variation of 6% for intra-observer variability and 9% for inter-observer variability, respectively. 
Definition of end point
The primary outcome was a composite of definite or suspected SCD, admission with documented VA or appropriate ICD discharge only in patients with a primary prophylactic ICD. 10 The cause of death was ascertained from hospital and pre-hospital patient records by two independent reviewers who were blinded to echocardiographic data, and information on all-cause mortality was obtained from the Danish Civil Registration System. For patients with a primary prophylactic ICD, the device was interrogated by an experienced electrophysiologist blinded to echocardiographic data.
Statistical analysis
Descriptive statistics
Relevant variables were tested for normality using visual inspection of histogram plots and are presented as mean ± SD or median [first and third quartiles (Q1-Q3)]. Continuous variables were compared using Student's t-test. Proportional differences were tested using v 2 statistics or Fisher's exact test where appropriate. All tests were two sided, and statistical significance was defined as P < 0.05.
Primary composite end point
The primary end point was a composite of VA or SCD. Proportional hazards assumptions were verified graphically. Cause-specific Cox regression models allowing for competing risks were used to identify univariate predictors of the primary composite outcome. The competing risk associated with the primary composite outcome was death from all causes other than SCD. Unadjusted cumulative incidence curves were calculated for the primary composite outcome stratified by tertiles of RVS and RV MD. Candidate variables with P-values of <0.05 in univariate analysis were included in the multivariable model using backward selection to test the independent association between outcome and RVS and RV MD, respectively. Receiver operating characteristic curve analysis with the use of a nonparametric estimate of the area under curve (AUC) and c-statistics with 95% confidence interval (CI) was performed for the multivariable model. For comparison between RVS and tricuspid annular plane systolic excursion (TAPSE), the strength of association with outcome for each parameter was compared using -2 log likelihood statistics. All statistical analyses were performed using SAS for Windows version 9.3 (SAS institute, Cary, NC, USA).
Results
Baseline characteristics and outcome
Of the 1110 patients, 790 patients with complete 2DSE data sets were included. Figure 1 shows a flowchart for patient selection. Mean age was 69 ± 12 years, 588 (74%) patients were male and 541 (69%) patients had ST-elevation MI. The baseline characteristics according to whether the patients experienced an end point or not are presented in Table 1 . Overall, patients who had an event were characterized by being older, more symptomatic (Killip class), having lower renal function and reduced myocardial function including both RV and LV function. With regard to RV function specifically, RVS and TAPSE were markedly lower in those with arrhythmic events compared with those without (-24.1 ± 5 vs. -19.8 ± 5, P < 0.0001 and 22 ± 4 vs. 20 ± 6, P < 0.0001), respectively. No significant differences were found in RV MD between patients with an event compared with those without (52 ± 23 vs. 58 ± 22, P = 0.2).
The median follow-up was 898 (Q1-Q3 704-981) days, and no patients were lost to follow-up. Overall, 31 patients experienced the primary end point. Six (19%) patients experienced the primary end point during the first 3 months. Of the total 31 events, 24 (77%) were attributed to SCD. Of the entire cohort, a total of 29 (3.6%) patients had a primary prophylactic ICD implanted during follow-up, of whom 6 of the 29 (21%) patients received appropriate therapy: four had an ICD shock and 2 received anti-tachycardia pacing. Thus, of the 31 patients with a primary end point 24 died from SCD, 6 had appropriate ICD therapy and 1 had VA.
Arrhythmia risk prediction by strain imaging of the right ventricle
Right ventricular free wall strain RVS was a strong predictor of arrhythmia. The better the RV function, the less likelihood of malignant arrhythmias. On Cox regression, a (numerical) reduction in negative strain of 1% was significantly associated with VA/SCD [hazard ratio (HR) 1.15 , 95% CI 1.08- 1.22 ; P < 0.001] and RVS remained independently associated with the 
outcome in a multivariable model including age and LV GLS (HR 1.08, 95% CI 1.01-1.15; P = 0.038) Table 2. Figure 3 shows the cumulative incidence function of the primary composite outcome SCD/VA stratified according to the tertiles of RVS. Patients in the lower tertile (poor strain) were highly prone to experience an event compared with patients in the upper tertile (HR 9.8, 95% CI 2.23-42.3; P = 0.002).
None of the covariates Killip class >1, estimated glomerular filtration rate, QRS duration, heart rate, LV MD or e/e 0 were found to be independently associated with outcome when separately added to a model including age and LV GLS. LV MD was only borderline significant when added to a model including LV GLS, age and RVS (HR 1.15, 95% CI 0.99-1.34; P = 0.08). In a model with LVEF, (rather than LV GLS) and age, RVS was independently associated with outcome (HR 1.12, 95% CI 1.03- 1.21 ; P = 0.005).
The mean RVS in patients with an inferior MI (culprit lesion right coronary artery) was significantly reduced in comparison with patients with other culprit lesions (culprit lesion circumflex, left main or left anterior descending artery) -22.7 ± 5.8 vs. -24,4 ± 4.9, P < 0.001. However, an inferior MI was not significantly associated with an increased risk of VA/SCD (P = 0.11).
RV mechanical dispersion RV MD as a continuous variable was not associated with outcome. However, patients with significantly increased dispersion >60 ms, corresponding to the upper tertile, had a 2.5-fold increased risk of VA/SCD compared with other patients. Figure 4 shows the cumulative incidence function of the primary composite outcome SCD/VA stratified according to tertiles of RV MD. However, a cut-off >60 ms for RV MD was not found to be independently associated with outcome. The correlation between RVS and mechanical dispersion was weak (r = 0.19, P < 0.001). 
Discussion
This is the first study to demonstrate the importance of RV dysfunction for development of SCD or VA in a post-MI population. The main finding was that RV dysfunction, measured by RVS, was independently associated with VA/SCD and superior to TAPSE in the prediction of VA/SCD. Furthermore, RV MD was a significant predictor of VA/SCD in univariate but not in multivariable analyses.
Although the RV is often referred to as 'the forgotten ventricle', recent studies have established the importance of RV function as an important determinant of clinical outcome in conditions such as pulmonary hypertension, 4 heart failure 4,5 and MI. 12,13,17 RV function not only does reflect the intrinsic contractility but may also to some degree be viewed as a sensitive barometer of any 'downstream pathology' affecting RV afterload due to abnormal pulmonary vasculature, increased LV filling pressures and other causes. 18 From the current study, it is evident that RV impairment is an important predictor of malignant arrhythmias independent of LV function. The relation between RV dysfunction and occurrence of VA/ SCD may to some degree be explained by the presence of areas with interwoven scar tissue and viable myocardium constituting substrates for slowed conduction leading to malignant re-entry arrhythmias much similar to the LV. This is supported by a study investigating RV involvement (based on ECG) in patients after inferior MI, where patients had an increased risk of death, shock and arrhythmias compared with patients without RV involvement after MI. 6 The results of the current study may also indicate that RV dysfunction in itself constitutes an arrhythmic substrate. 7 In line with our findings, La Gerche et al. 19 has reported that athletes with previous RV arrhythmia have RV contractile dysfunction that can be revealed by exercise testing. Previous evidence for the importance of RV dysfunction for the occurrence of VA/SCD is, however, sparse. In a smaller study of 222 patients with primary prophylactic ICD, Aktas et al. 20 found RV dysfunction to be predictive of the combined end point of VA and allcause death but not on ICD therapy alone. Doyle et al. 7 suggested in a substudy from MADIT-CRT that enlarged RV size (as an indirect measure of RV function) was closely associated with the occurrence of VA or death and that this risk was reduced by resynchronization therapy when RV remodelling occurred.
2D strain analysis of the right ventricle
RV function was evaluated by 2DSE. This technique has previously been proved to provide a valuable tool in the prediction of arrhythmic events when applied to the LV. In particular, GLS has been demonstrated to be a critical determinant of VA as well as superior to conventional parameters of LV function, such as LVEF, for risk stratification. 10, 14 The idea is that GLS includes information regarding subtle changes in myocardial function caused by the early deterioration of endocardial longitudinal fibre function and therefore is a more sensitive marker than conventional measures. Several previous studies have demonstrated that 2DSE can be applied to the RV in a simple and feasible manner similar to the LV. 8, 9 Two studies in post-MI cohorts recently reported that RV dysfunction assessed by 2DSE was closely associated with long-term survival and major cardiac events. 13, 21 One study by Park et al. 13 included the entire RV in the analysis based on vector velocity imaging for deformation analysis, while the other by Antoni et al. 21 addressed the RV free wall only by speckle tracking. There has been some contention over whether the interventricular septum should be included in the measurement of global RV function. We decided to use RVS, because the interventricular septum was included in LV GLS assessment.
RV mechanical dispersion
As part of RV strain evaluation, the prognostic value of RV mechanical dispersion was investigated. The mechanical dispersion is a measure of contractile heterogeneity and is determined by multiple factors such as the presence of scar tissue, fibrosis, electrical activation and loading conditions. An abnormal mechanical dispersion may reflect heterogeneities in the electrical conduction, which may lead to ventricular arrhythmias. Several studies, across different patient cohorts, have proposed that mechanical dispersion can be used in the prediction of arrhythmias when applied to the LV, although the clinical utility of this marker has been questioned lately. 10, 22, 23 Only one study has reported on the predictive ability of RV mechanical dispersion. 16 Sarvari et al. 16 showed that arrhythmogenic right ventricular cardiomyopathy (ARVC) patients have increased RV MD compared with the healthy controls and that this is associated with increased occurrence of ventricular arrhythmias. The current cohort represents a very different pathophysiology, which may be the reason we do not find an important role for RV MD in post-AMI patients.
Patients with RV MD in the upper tertile did have more than a 2-fold increased risk of VA/SCD compared with other patients. However, RV MD was not independently associated with outcome. Figure 5 The correlation between parameters of RV function;
TAPSE and RVS in relation to whether patients experienced an event or not. 
Limitations
The primary outcome VA/SCD is relatively rare in a post-AMI cohort. This may to some degree have compromised the statistical analysis due to potential overfitting of the multivariable models and covariates with prognostic value may have been discarded. This is, however, the largest study to date addressing this topic. The time from presentation can be important, and surely, it is unknown whether an echo performed at another time would show similar results. The approach used in the present study ensured that patient echoes were comparable and the timing just before discharge, is in our opinion, a clinically relevant time for assessment of patient prognosis.
It was only possible to obtain RVS in 80.5% of cases. This was primarily due to our strict criteria regarding RV free wall assessment, which required reliable tracking in all three segments (basal, midventricular and apical) to be included. It may be that reliable tracking in two segments can be a useful approach. This was not tested in the present study.
In retrospect, not all studies were focused on the RV-four chambers only but some also included the right atrium. 24 However, images were always optimized at frame rates between 50 and 90 frames/min. In addition, it could be argued that RVOT flow recordings would be more correct than using aortic flow recordings to define end systole, and this may have caused minor variations in RVS measurements.
For evaluation of RV function, RVFAC is often reported. 12, 13 This measure was not included in the current study, because it was not part of the predefined echo analysis protocol. Instead, RVS was compared with TAPSE, which has been reported to be a strong clinical parameter of equal value for prediction of clinical outcome. We find that the lack of RVFAC is of limited importance for the overall conclusions, but surely no conclusions involving this parameter should be drawn based on the current study.
Conclusion
Assessment of RV function by RVS may improve the prediction of SCD/VA in patients with acute MI, but RV mechanical dispersion is not independently associated with outcome. The use of 2DSE for the assessment of RV function was found to have an incremental value in comparison with the conventional measure TAPSE for the prediction of VA or SCD. 
